About Homology Medicines, Inc.
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
|
|
11-50 employees
View all Homology Medicines, Inc. employees
|
|
Biotechnology Research
|
|
1 Patriots Park, Bedford, Massachusetts 01730, US
|
|
2015
|
|
Biotechnology, Gene Therapy, Rare Diseases, Gene Editing
|
Homology Medicines, Inc. Alternatives
Frequently Asked Questions about Homology Medicines, Inc.
Albert Seymour is the CEO of Homology Medicines, Inc..
The decision makers in Homology Medicines, Inc. are Arthur Tzianabos, Brian Seigel, Carmen Barnes, etc. Click to Find Homology Medicines, Inc. decision makers emails.
Homology Medicines, Inc. Staff Directory
Search Homology Medicines, Inc. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
